Betty Dong, PharmD
Professor
Clinical Pharmacy
School of Pharmacy

Betty Dong, PharmD, FCCP, FASHP, FAPHA, AAHIVP provides pharmacy care under a collaborative prescribing protocol for patients with HIV and HCV infection, and chronic disease states, including hypertension, anticoagulation, diabetes, thyroid, and medication nonadherence.

Show full bio (70 words) Hide full bio

She provides patient education, and medication and side effect monitoring for persons seen at the Family Health Center located at Zuckerberg San Francisco General Hospital. She is a senior consultant for the Clinicians' Consultation Center on the treatment and prevention of HIV, HBV, and HCV infection in adults, children, and during pregnancy. She has published, lectured, and conducted research in the aforementioned areas.

Awards

Show all (17) Hide

• Special Recognition: ACSAP Editors, American College of Clinical Pharmacy, 2019
• Daniel B. Smith Practice Excellence Award, American Pharmacist Association, 2019
• Dean's Recognition for Excellence in Teaching, UCSF School of Pharmacy, 2018-2019
• Honorable Mention Hepatitis C Champion, Hepatitis Task Force San Francisco, CA, 2017
• Distinguished Person of the Year, Pharmacists Planning Services, INC (PPSI), 2016
• Elected Practitioner, National Association of Practitioners, 2012
• Distinguished Alumni, UCSF School of Pharmacy Alumni Association, 2010
• Clinical Practice Award, American College of Clinical Pharmacy, 2004
• Elected Fellow, American College of Clinical Pharmacy, 2004
• Elected Fellow, American Society of Health System Pharmacists, 2004
• Anniversary Year Alumnus, Commencement Ceremony Class 2002, UCSF School of Pharmacy, 2002
• Pharmacist of the Year, California Society of Health System Pharmacists, 2001-2002
• Residency Preceptor Award, UCSF Pharmacy Residents, Division of Clinical Pharmacy, 1990-1991
• Practitioner Fellow, California Society of Health System Pharmacists, 1990
• Outstanding Teaching Award - Family Practice Residency Program, SFGH; Department of Family and Commu, UCSF Department of FCM, 1988
• Long Froundation Award, UCSF School of Pharmacy, 1987
• NewHouse Award, UCSF, 1971-1972

Education & Training

Show all (2) Hide

• Pharm.D. School of Pharmacy University of California, San Francisco 1972
• Residency School of Pharmacy University of California, San Francisco

Websites

Show all (1) Hide

• UCSF Department of Clinical Pharmacy Profile (clinicalpharmacy.ucsf.edu)

Grants and Projects

Show all (1) Hide

• General Clinical Research Center, NIH, 1974-2007

Publications (22)

Top publication keywords:
Anti-HIV AgentsRemote ConsultationTelecommunicationsHepatitis CPre-Exposure ProphylaxisReverse Transcriptase InhibitorsPoint-of-Care SystemsExanthemaAntibodiesPharmacistsPharmaciesFamily PracticeNevirapineCommunity Pharmacy ServicesHIV Infections

• Patterns of Prescribing Antiretroviral Therapy Upon Discharge to Psychiatry Inpatients With HIV/AIDS at a Large Urban Hospital.
  The Annals of pharmacotherapy 2020 Momenzadeh A, Shumway M, Dong BJ, Dilley J, Nye J, Mangurian C
• Community pharmacy delivered PrEP to STOP HIV transmission: An opportunity NOT to miss!
  Journal of the American Pharmacists Association : JAPhA 2020 Lopez MI, Grant RM, Dong BJ
• Response to: Acceptability and Feasibility of a Pharmacist-Led HIV Pre-exposure Prophylaxis Program in the Midwestern United States.
  Open forum infectious diseases 2019 Dong BJ, Lopez MI, Grant RM
• Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health.
  Journal of the American Pharmacists Association : JAPhA 2019 Lopez MI, Cocohoba J, Cohen SE, Trainor N, Levy MM, Dong BJ
• Outcome of challenging HIV case consultations provided via teleconference by the Clinician Consultation Center to the Federal Bureau of Prisons.
  Journal of the American Pharmacists Association : JAPhA 2017 Dong BJ, Williams MR, Bingham JT, Tokumoto J, Allen JD
• Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
  Journal of the American Pharmacists Association : JAPhA 2017 Dong BJ, Lopez M, Cocohoba J
• Initial Management of Patients with HIV Infection.
  American family physician 2016 Goldschmidt RH, Chu C, Dong BJ
• Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.
  Expert opinion on drug safety 2016 Trang TP, Dong BJ, Kojima N, Klausner JD
• Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.
  Pharmacotherapy 2014 Mohammad RA, Bulloch MN, Chan J, Deming P, Love B, Smith L, Dong BJ
• Reporting of critical information in studies of pharmacists in HIV care.
  The International journal of pharmacy practice 2014 Cocohoba J, Dong BJ, Johnson MO, Saberi P
• Center for the Advancement of Pharmacy Education 2013 educational outcomes.
  American journal of pharmaceutical education 2013 Medina MS, Plaza CM, Stowe CD, Robinson ET, DeLander G, Beck DE, Melchert RB, Supernaw RB, Roche VF, Gleason BL, Strong MN, Bain A, Meyer GE, Dong BJ, Rochon J, Johnston P
• Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.
  AIDS (London, England) 2012 Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT, AIDS Clinical Trials Group Study 5208 Team
• The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review.
  Patient preference and adherence 2012 Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM
• Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians' Consultation Center.
  The Annals of pharmacotherapy 2011 Sherman EM, Cocohoba JM, Neff SE, Dong BJ
• Raltegravir: the first HIV integrase inhibitor.
  Clinical therapeutics 2008 Cocohoba J, Dong BJ
• Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program.
  The Annals of pharmacotherapy 2008 Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ
• Tipranavir: a protease inhibitor for HIV salvage therapy.
  The Annals of pharmacotherapy 2006 Dong BJ, Cocohoba JM
• Advances in human immunodeficiency virus therapeutics.
  The Annals of pharmacotherapy 2006 Clay PG, Dong BJ, Sorensen SJ, Tseng A, Romanelli F, Antoniou T
• Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
  Clinical therapeutics 2005 Dong BJ
• Outcomes of dual-protease inhibitor salvage therapy in human immunodeficiency virus-infected patients referred to a telephone consultation service.
  Pharmacotherapy 2003 Lim ML, Dong BJ, Hart SL
• Treatment of AIDS and HIV-related conditions--2002: antiretroviral therapy.
  The Journal of the American Board of Family Practice 2002 Goldschrnidt RH, Dong BJ
• Opportunities to Increase Access to HIV Prevention: Evaluating the Implementation of Pharmacist-Initiated Pre-exposure Prophylaxis in California.
  Open forum infectious diseases 2023 Hunter LA, Packel LJ, Chitle P, Beltran RM, Rafie S, De Martini L, Dong B, Harris O, Holloway IW, Miyashita Ochoa A, McCoy SI